Exact Mass: 731.5158317999999

Exact Mass Matches: 731.5158317999999

Found 500 metabolites which its exact mass value is equals to given mass value 731.5158317999999, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

PC(16:0/16:1(9Z))

(R-(Z))-4-Hydroxy-N,N,N-trimethyl-10-oxo-7-((1-oxo-9-hexadecenyl)oxy)-3,5,9-trioxa-4-phosphapentacosan-1-aminium, hydroxide, inner salt, 4-oxide

C40H78NO8P (731.5464757999999)


PC(16:0/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/16:1(9Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

Araliacerebroside

N-[(8E)-3,4-Dihydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-8-en-2-yl]-2-hydroxyhexadecanimidate

C40H77NO10 (731.5547182)


Araliacerebroside is found in green vegetables. Araliacerebroside is a constituent of the root bark of Aralia elata (Japanese angelica tree). Constituent of the root bark of Aralia elata (Japanese angelica tree). Araliacerebroside is found in green vegetables.

   

PC(14:0/18:1(11Z))

trimethyl(2-{[(2R)-2-[(11Z)-octadec-11-enoyloxy]-3-(tetradecanoyloxy)propyl phosphonato]oxy}ethyl)azanium

C40H78NO8P (731.5464757999999)


PC(14:0/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/18:1(11Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(14:0/18:1)

trimethyl(2-{[(2R)-2-[(9Z)-octadec-9-enoyloxy]-3-(tetradecanoyloxy)propyl phosphonato]oxy}ethyl)azanium

C40H78NO8P (731.5464758)


PC(14:0/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/18:1(9Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of oleic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(14:1(9Z)/18:0)

trimethyl(2-{[(2R)-2-(octadecanoyloxy)-3-[(9Z)-tetradec-9-enoyloxy]propyl phosphonato]oxy}ethyl)azanium

C40H78NO8P (731.5464757999999)


PC(14:1(9Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:1(9Z)/18:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of stearic acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(16:1(9Z)/16:0)

(2-{[(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-(hexadecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C40H78NO8P (731.5464757999999)


PC(16:1(9Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/16:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(16:1(9Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/16:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(18:0/14:1(9Z))

trimethyl(2-{[(2R)-3-(octadecanoyloxy)-2-[(9Z)-tetradec-9-enoyloxy]propyl phosphonato]oxy}ethyl)azanium

C40H78NO8P (731.5464757999999)


PC(18:0/14:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/14:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(18:0/14:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/14:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(18:1(11Z)/14:0)

trimethyl(2-{[(2R)-3-[(11Z)-octadec-11-enoyloxy]-2-(tetradecanoyloxy)propyl phosphonato]oxy}ethyl)azanium

C40H78NO8P (731.5464757999999)


PC(18:1(11Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/14:0), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of myristic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(18:1(9Z)/14:0)

trimethyl(2-{[(2R)-3-[(9Z)-octadec-9-enoyloxy]-2-(tetradecanoyloxy)propyl phosphonato]oxy}ethyl)azanium

C40H78NO8P (731.5464757999999)


PC(18:1(9Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/14:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of myristic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PE(15:0/20:1(11Z))

(2-aminoethoxy)[(2R)-2-[(11Z)-icos-11-enoyloxy]-3-(pentadecanoyloxy)propoxy]phosphinic acid

C40H78NO8P (731.5464757999999)


PE(15:0/20:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(15:0/20:1(11Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(20:1(11Z)/15:0)

(2-aminoethoxy)[(2R)-3-[(11Z)-icos-11-enoyloxy]-2-(pentadecanoyloxy)propoxy]phosphinic acid

C40H78NO8P (731.5464757999999)


PE(20:1(11Z)/15:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/15:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(20:1(11Z)/15:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/15:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(16:0/18:1(9Z))

[(2R)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid

C40H78NO8P (731.5464757999999)


PE-NMe(16:0/18:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:0/18:1(9Z)), in particular, consists of one hexadecanoyl chain to the C-1 atom, and one 9Z-octadecenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. PE-NMe(16:0/18:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. (Lipid Library, Lipid MAPS) [HMDB]

   

PS(14:0/18:2(9Z,12Z))

(2S)-2-amino-3-({hydroxy[(2R)-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]-3-(tetradecanoyloxy)propoxy]phosphoryl}oxy)propanoic acid

C38H70NO10P (731.473709)


PS(14:0/18:2(9Z,12Z)) is a phosphatidylserine (PS or GPSer). It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoserines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PS(14:0/18:2(9Z,12Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of linoleic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the linoleic acid moiety is derived from seed oils. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. It is usually less than 10\\% of the total phospholipids, the greatest concentration being in myelin from brain tissue. However, it may comprise 10 to 20 mol\\% of the total phospholipid in the plasma membrane and endoplasmic reticulum of the cell. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine, especially during bone formation for example. As phosphatidylserine is located entirely on the inner monolayer surface of the plasma membrane (and of other cellular membranes) and it is the most abundant anionic phospholipids. Therefore phosphatidylseriine may make the largest contribution to interfacial effects in membranes involving non-specific electrostatic interactions. This normal distribution is disturbed during platelet activation and cellular apoptosis. In human plasma, 1-stearoyl-2-oleoyl and 1-stearoyl-2-arachidonoyl species predominate, but in brain (especially grey matter), retina and many other tissues 1-stearoyl-2-docosahexaenoyl species are very abundant. Indeed, the ratio of n-3 to n-6 fatty acids in brain phosphatidylserine is very much higher than in most other lipids. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE. PS(14:0/18:2(9Z,12Z)) is a phosphatidylserine (PS or GPSer). It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoserines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PS(14:0/18:2(9Z,12Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of linoleic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the linoleic acid moiety is derived from seed oils. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. It is usually less than 10\\% of the total phospholipids, the greatest concentration being in myelin from brain tissue. However, it may comprise 10 to 20 mol\\% of the total phospholipid in the plasma membrane and endoplasmic reticulum of the cell. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine, especially during bone formation for example. As phosphatidylserine is located entirely on the inner monolayer surface of the plasma membrane (and of other cellular membranes) and it is the most abundant anionic phospholipids. Therefore phosphatidylseriine may make the largest contribution to interfacial effects in membranes involving non-specific electrostatic interactions. This normal distribution is disturbed during platelet activation and cellular apoptosis. In human plasma, 1-stearoyl-2-oleoyl and 1-stearoyl-2-arachidonoyl species predominate, but in brain (especially grey matter), retina and many other tissues 1-stearoyl-2-docosahexaenoyl species are very abundant. Indeed, the ratio of n-3 to n-6 fatty acids in brain phosphatidylserine is very much higher than in most other lipids.

   

PS(14:1(9Z)/18:1(9Z))

(2S)-2-amino-3-({hydroxy[(2R)-2-[(9Z)-octadec-9-enoyloxy]-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphoryl}oxy)propanoic acid

C38H70NO10P (731.473709)


PS(14:1(9Z)/18:1(9Z)) is a phosphatidylserine (PS or GPSer). It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoserines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PS(14:1(9Z)/18:1(9Z)), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of oleic acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. It is usually less than 10\\% of the total phospholipids, the greatest concentration being in myelin from brain tissue. However, it may comprise 10 to 20 mol\\% of the total phospholipid in the plasma membrane and endoplasmic reticulum of the cell. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine, especially during bone formation for example. As phosphatidylserine is located entirely on the inner monolayer surface of the plasma membrane (and of other cellular membranes) and it is the most abundant anionic phospholipids. Therefore phosphatidylseriine may make the largest contribution to interfacial effects in membranes involving non-specific electrostatic interactions. This normal distribution is disturbed during platelet activation and cellular apoptosis. In human plasma, 1-stearoyl-2-oleoyl and 1-stearoyl-2-arachidonoyl species predominate, but in brain (especially grey matter), retina and many other tissues 1-stearoyl-2-docosahexaenoyl species are very abundant. Indeed, the ratio of n-3 to n-6 fatty acids in brain phosphatidylserine is very much higher than in most other lipids. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE. PS(14:1(9Z)/18:1(9Z)) is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PS(14:1(9Z)/18:1(9Z)), in particular, consists of one 9Z-tetradecenoyl chain to the C-1 atom, and one 9Z-octadecenoyl to the C-2 atom. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.

   

PS(16:1(9Z)/16:1(9Z))

(2S)-2-amino-3-({[(2R)-2,3-bis[(9Z)-hexadec-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)propanoic acid

C38H70NO10P (731.473709)


PS(16:1(9Z)/16:1(9Z)) is a phosphatidylserine (PS or GPSer). It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoserines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PS(16:1(9Z)/16:1(9Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. It is usually less than 10\\% of the total phospholipids, the greatest concentration being in myelin from brain tissue. However, it may comprise 10 to 20 mol\\% of the total phospholipid in the plasma membrane and endoplasmic reticulum of the cell. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine, especially during bone formation for example. As phosphatidylserine is located entirely on the inner monolayer surface of the plasma membrane (and of other cellular membranes) and it is the most abundant anionic phospholipids. Therefore phosphatidylseriine may make the largest contribution to interfacial effects in membranes involving non-specific electrostatic interactions. This normal distribution is disturbed during platelet activation and cellular apoptosis. In human plasma, 1-stearoyl-2-oleoyl and 1-stearoyl-2-arachidonoyl species predominate, but in brain (especially grey matter), retina and many other tissues 1-stearoyl-2-docosahexaenoyl species are very abundant. Indeed, the ratio of n-3 to n-6 fatty acids in brain phosphatidylserine is very much higher than in most other lipids. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE. PS(16:1(9Z)/16:1(9Z)) is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. PS(16:1(9Z)/16:1(9Z)), in particular, consists of two 9Z-hexadecenoyl chains at positions C-1 and C-2. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.

   

PS(18:1(9Z)/14:1(9Z))

(2S)-2-amino-3-({hydroxy[(2R)-3-[(9Z)-octadec-9-enoyloxy]-2-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphoryl}oxy)propanoic acid

C38H70NO10P (731.473709)


PS(18:1(9Z)/14:1(9Z)) is a phosphatidylserine (PS or GPSer). It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoserines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PS(18:1(9Z)/14:1(9Z)), in particular, consists of one chain of oleic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the myristoleic acid moiety is derived from milk fats. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. It is usually less than 10\\% of the total phospholipids, the greatest concentration being in myelin from brain tissue. However, it may comprise 10 to 20 mol\\% of the total phospholipid in the plasma membrane and endoplasmic reticulum of the cell. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine, especially during bone formation for example. As phosphatidylserine is located entirely on the inner monolayer surface of the plasma membrane (and of other cellular membranes) and it is the most abundant anionic phospholipids. Therefore phosphatidylseriine may make the largest contribution to interfacial effects in membranes involving non-specific electrostatic interactions. This normal distribution is disturbed during platelet activation and cellular apoptosis. In human plasma, 1-stearoyl-2-oleoyl and 1-stearoyl-2-arachidonoyl species predominate, but in brain (especially grey matter), retina and many other tissues 1-stearoyl-2-docosahexaenoyl species are very abundant. Indeed, the ratio of n-3 to n-6 fatty acids in brain phosphatidylserine is very much higher than in most other lipids. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE. PS(18:1(9Z)/14:1(9Z)) is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PS(18:1(9Z)/14:1(9Z)), in particular, consists of one 9Z-octadecenoyl chain to the C-1 atom, and one 9Z-tetradecenoyl to the C-2 atom. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.

   

PS(18:2(9Z,12Z)/14:0)

(2S)-2-amino-3-({hydroxy[(2R)-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]-2-(tetradecanoyloxy)propoxy]phosphoryl}oxy)propanoic acid

C38H70NO10P (731.473709)


PS(18:2(9Z,12Z)/14:0) is a phosphatidylserine (PS or GPSer). It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoserines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PS(18:2(9Z,12Z)/14:0), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of myristic acid at the C-2 position. The linoleic acid moiety is derived from seed oils, while the myristic acid moiety is derived from nutmeg and butter. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. It is usually less than 10\\% of the total phospholipids, the greatest concentration being in myelin from brain tissue. However, it may comprise 10 to 20 mol\\% of the total phospholipid in the plasma membrane and endoplasmic reticulum of the cell. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine, especially during bone formation for example. As phosphatidylserine is located entirely on the inner monolayer surface of the plasma membrane (and of other cellular membranes) and it is the most abundant anionic phospholipids. Therefore phosphatidylseriine may make the largest contribution to interfacial effects in membranes involving non-specific electrostatic interactions. This normal distribution is disturbed during platelet activation and cellular apoptosis. In human plasma, 1-stearoyl-2-oleoyl and 1-stearoyl-2-arachidonoyl species predominate, but in brain (especially grey matter), retina and many other tissues 1-stearoyl-2-docosahexaenoyl species are very abundant. Indeed, the ratio of n-3 to n-6 fatty acids in brain phosphatidylserine is very much higher than in most other lipids. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE. PS(18:2(9Z,12Z)/14:0) is a phosphatidylserine (PS or GPSer). It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoserines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PS(18:2(9Z,12Z)/14:0), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of myristic acid at the C-2 position. The linoleic acid moiety is derived from seed oils, while the myristic acid moiety is derived from nutmeg and butter. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. It is usually less than 10\\% of the total phospholipids, the greatest concentration being in myelin from brain tissue. However, it may comprise 10 to 20 mol\\% of the total phospholipid in the plasma membrane and endoplasmic reticulum of the cell. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine, especially during bone formation for example. As phosphatidylserine is located entirely on the inner monolayer surface of the plasma membrane (and of other cellular membranes) and it is the most abundant anionic phospholipids. Therefore phosphatidylseriine may make the largest contribution to interfacial effects in membranes involving non-specific electrostatic interactions. This normal distribution is disturbed during platelet activation and cellular apoptosis. In human plasma, 1-stearoyl-2-oleoyl and 1-stearoyl-2-arachidonoyl species predominate, but in brain (especially grey matter), retina and many other tissues 1-stearoyl-2-docosahexaenoyl species are very abundant. Indeed, the ratio of n-3 to n-6 fatty acids in brain phosphatidylserine is very much higher than in most other lipids.

   

PS(14:1(9Z)/18:1(11Z))

(2S)-2-amino-3-({hydroxy[(2R)-2-[(11Z)-octadec-11-enoyloxy]-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphoryl}oxy)propanoic acid

C38H70NO10P (731.473709)


PS(14:1(9Z)/18:1(11Z)) is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PS(14:1(9Z)/18:1(11Z)), in particular, consists of one 9Z-tetradecenoyl chain to the C-1 atom, and one 11Z-octadecenoyl to the C-2 atom. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.

   

PS(18:1(11Z)/14:1(9Z))

(2S)-2-amino-3-{[hydroxy((2R)-3-[(11Z)-octadec-11-enoyloxy]-2-[(9Z)-tetradec-9-enoyloxy]propoxy)phosphoryl]oxy}propanoic acid

C38H70NO10P (731.473709)


PS(18:1(11Z)/14:1(9Z)) is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. PS(18:1(11Z)/14:1(9Z)), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants, and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups (i.e. the phosphate moiety, the amino group and the carboxyl group). As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have a palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.

   

PE-NMe(14:0/20:1(11Z))

{2-[(11Z)-icos-11-enoyloxy]-3-(tetradecanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid

C40H78NO8P (731.5464757999999)


PE-NMe(14:0/20:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(14:0/20:1(11Z)), in particular, consists of one tetradecanoyl chain to the C-1 atom, and one 11Z-eicosenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(14:1(9Z)/20:0)

[2-(icosanoyloxy)-3-[(9Z)-tetradec-9-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid

C40H78NO8P (731.5464757999999)


PE-NMe(14:1(9Z)/20:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(14:1(9Z)/20:0), in particular, consists of one 9Z-tetradecenoyl chain to the C-1 atom, and one eicosanoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(16:0/18:1(11Z))

[3-(hexadecanoyloxy)-2-[(11Z)-octadec-11-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid

C40H78NO8P (731.5464757999999)


PE-NMe(16:0/18:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:0/18:1(11Z)), in particular, consists of one hexadecanoyl chain to the C-1 atom, and one 11Z-octadecenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(16:1(9Z)/18:0)

{3-[(9Z)-hexadec-9-enoyloxy]-2-(octadecanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid

C40H78NO8P (731.5464757999999)


PE-NMe(16:1(9Z)/18:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:1(9Z)/18:0), in particular, consists of one 9Z-hexadecenoyl chain to the C-1 atom, and one octadecanoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(18:0/16:1(9Z))

{2-[(9Z)-hexadec-9-enoyloxy]-3-(octadecanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid

C40H78NO8P (731.5464757999999)


PE-NMe(18:0/16:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:0/16:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(18:1(11Z)/16:0)

[2-(hexadecanoyloxy)-3-[(11Z)-octadec-11-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid

C40H78NO8P (731.5464757999999)


PE-NMe(18:1(11Z)/16:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(11Z)/16:0), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(18:1(9Z)/16:0)

[2-hexadecanoyloxy-3-[hydroxy-[2-(methylamino)ethoxy]phosphoryl]oxypropyl] (Z)-octadec-9-enoate

C40H78NO8P (731.5464757999999)


PE-NMe(18:1(9Z)/16:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(9Z)/16:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(20:0/14:1(9Z))

[3-(icosanoyloxy)-2-[(9Z)-tetradec-9-enoyloxy]propoxy][2-(methylamino)ethoxy]phosphinic acid

C40H78NO8P (731.5464757999999)


PE-NMe(20:0/14:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:0/14:1(9Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(20:1(11Z)/14:0)

{3-[(11Z)-icos-11-enoyloxy]-2-(tetradecanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid

C40H78NO8P (731.5464757999999)


PE-NMe(20:1(11Z)/14:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:1(11Z)/14:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of myristic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(15:0/18:1(9Z))

[2-(dimethylamino)ethoxy]({2-[(9Z)-octadec-9-enoyloxy]-3-(pentadecanoyloxy)propoxy})phosphinic acid

C40H78NO8P (731.5464757999999)


PE-NMe2(15:0/18:1(9Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(15:0/18:1(9Z)), in particular, consists of one pentadecanoyl chain to the C-1 atom, and one 9Z-octadecenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe2(15:0/18:1(11Z))

PE-NMe2(15:0/18:1(11Z))

C40H78NO8P (731.5464757999999)


PE-NMe2(15:0/18:1(11Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(15:0/18:1(11Z)), in particular, consists of one pentadecanoyl chain to the C-1 atom, and one 11Z-octadecenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe2(18:1(11Z)/15:0)

[2-(dimethylamino)ethoxy]({3-[(11Z)-octadec-11-enoyloxy]-2-(pentadecanoyloxy)propoxy})phosphinic acid

C40H78NO8P (731.5464757999999)


PE-NMe2(18:1(11Z)/15:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:1(11Z)/15:0), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(18:1(9Z)/15:0)

[2-(dimethylamino)ethoxy]({3-[(9Z)-octadec-9-enoyloxy]-2-(pentadecanoyloxy)propoxy})phosphinic acid

C40H78NO8P (731.5464757999999)


PE-NMe2(18:1(9Z)/15:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:1(9Z)/15:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

Auristatin E

2-(dimethylamino)-N-(1-{[1-(2-{2-[(1-hydroxy-1-phenylpropan-2-yl)carbamoyl]-1-methoxy-2-methylethyl}pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl](methyl)carbamoyl}-2-methylpropyl)-3-methylbutanamide

C40H69N5O7 (731.5196724)


   

Mmaf

2-(2-{[1-(4-{N,3-dimethyl-2-[3-methyl-2-(methylamino)butanamido]butanamido}-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl](methoxy)methyl}propanamido)-3-phenylpropanoic acid

C39H65N5O8 (731.483289)


   

PE(16:0/18:1(12Z)-O(9S,10R))

(2-aminoethoxy)[(2R)-3-(hexadecanoyloxy)-2-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propoxy]phosphinic acid

C39H74NO9P (731.5100924)


PE(16:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(16:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one hexadecanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(18:1(12Z)-O(9S,10R)/16:0)

(2-aminoethoxy)[(2R)-2-(hexadecanoyloxy)-3-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propoxy]phosphinic acid

C39H74NO9P (731.5100924)


PE(18:1(12Z)-O(9S,10R)/16:0) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(18:1(12Z)-O(9S,10R)/16:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of hexadecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(16:0/18:1(9Z)-O(12,13))

(2-aminoethoxy)[(2R)-3-(hexadecanoyloxy)-2-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphinic acid

C39H74NO9P (731.5100924)


PE(16:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(16:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one hexadecanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(18:1(9Z)-O(12,13)/16:0)

(2-aminoethoxy)[(2R)-2-(hexadecanoyloxy)-3-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphinic acid

C39H74NO9P (731.5100924)


PE(18:1(9Z)-O(12,13)/16:0) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(18:1(9Z)-O(12,13)/16:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of hexadecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   
   

Phosphatidylethanolamine 17:0-18:1

Phosphatidylethanolamine 17:0-18:1

C40H78NO8P (731.5464757999999)


   
   

1-O-(beta-D-glucopyranosyloxy)-(2S,3S,4R,6E)-2[(2R)-2-hydroxyheptadecanoylamino]-8-heptadecene-3,4-diol

1-O-(beta-D-glucopyranosyloxy)-(2S,3S,4R,6E)-2[(2R)-2-hydroxyheptadecanoylamino]-8-heptadecene-3,4-diol

C40H77NO10 (731.5547182)


   

1-O-beta-D-glucopyranosyl-(2S,3S,4R,6E)-[2(R)-2-hydroxypalmitoylamino]-6-octadecene-1,3,4-triol|hippophae cerebroside

1-O-beta-D-glucopyranosyl-(2S,3S,4R,6E)-[2(R)-2-hydroxypalmitoylamino]-6-octadecene-1,3,4-triol|hippophae cerebroside

C40H77NO10 (731.5547182)


   

Microcolin B

[(2R,3S)-3-[[(2S)-2-[[(2R,4R)-2,4-Dimethyloctanoyl]-methylamino]-4-methylpentanoyl]amino]-4-[methyl-[(2S)-3-methyl-1-[(2S)-2-[(2S)-2-methyl-5-oxo-2H-pyrrole-1-carbonyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]amino]-4-oxobutan-2-yl] acetate

C39H65N5O8 (731.483289)


[(2R,3S)-3-[[(2S)-2-[[(2R,4R)-2,4-dimethyloctanoyl]-methylamino]-4-methylpentanoyl]amino]-4-[methyl-[(2S)-3-methyl-1-[(2S)-2-[(2S)-2-methyl-5-oxo-2H-pyrrole-1-carbonyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]amino]-4-oxobutan-2-yl] acetate is a natural product found in Lyngbya majuscula with data available.

   

(2R)-N-{(1S,2S,3R,8E)-1-[(beta-D-glucopyranosyloxy)methyl]-2,3-dihydroxyheptadec-8-en-1-yl}-2-hydroxyhexadecanamide

(2R)-N-{(1S,2S,3R,8E)-1-[(beta-D-glucopyranosyloxy)methyl]-2,3-dihydroxyheptadec-8-en-1-yl}-2-hydroxyhexadecanamide

C40H77NO10 (731.5547182)


   
   

1-O-beta-D-glucopyranosyl-(2S,3S,4R,9E)-2-[(2R)-2-hydroxyeicosanoylamino]-9-tetradecene-1,3,4-triol

1-O-beta-D-glucopyranosyl-(2S,3S,4R,9E)-2-[(2R)-2-hydroxyeicosanoylamino]-9-tetradecene-1,3,4-triol

C40H77NO10 (731.5547182)


   

1,3,4,12-tetrahydroxy-2-(9-hexadecenoylamino)octadecane 1-O-glucopyranoside|bonaroside

1,3,4,12-tetrahydroxy-2-(9-hexadecenoylamino)octadecane 1-O-glucopyranoside|bonaroside

C40H77NO10 (731.5547182)


   

PC 32:1

1-(11Z-octadecenoyl)-2-tetradecanoyl-sn-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


Found in mouse lung; TwoDicalId=14; MgfFile=160901_Lung_normal_Neg_03; MgfId=735

   

1,2-Dierucoyl-sn-glycero-3-phosphoethanolamine

1,2-Dierucoyl-sn-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

PC(14:0/18:1)[U]

3,5,8-Trioxa-4-phosphahexacos-17-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxotetradecyl)oxy]methyl]-, inner salt, 4-oxide, (Z)-

C40H78NO8P (731.5464757999999)


   

PC(16:0/16:1)[U]

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-hexadecenyl)oxy]-, inner salt, 4-oxide, (Z)-

C40H78NO8P (731.5464757999999)


   

PC(18:1/14:0)[U]

3,5,9-Trioxa-4-phosphaheptacos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxotetradecyl)oxy]-, inner salt, 4-oxide, (Z)-

C40H78NO8P (731.5464757999999)


   

PE-NMe(16:0/18:1)[U]

9-Octadecenoic acid (Z)-, 1-(3-hydroxy-2,4-dioxa-7-aza-3-phosphaoct-1-yl)-2-[(1-oxohexadecyl)oxy]ethyl ester, P-oxide

C40H78NO8P (731.5464757999999)


   

PE-NMe(16:0/18:1)

9-Octadecenoic acid (Z)-, 4-hydroxy-1-[[(1-oxohexadecyl)oxy]methyl]-3,5-dioxa-8-aza-4-phosphanon-1-yl ester, P-oxide, (R)-

C40H78NO8P (731.5464757999999)


   

PE-NMe(18:1/16:0)

9-Octadecenoic acid (Z)-, 5-hydroxy-5-oxido-2-[(1-oxohexadecyl)oxy]-4,6-dioxa-9-aza-5-phosphadeca-1-yl ester, (R)-

C40H78NO8P (731.5464757999999)


   

1-(6-[3]-ladderane-hexanyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine

1-(6-[3]-ladderane-hexanyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine

C43H74NO6P (731.5253473999999)


   

Lecithin

1-Palmitoleoyl-2-palmitoyl-sn-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

PE(35:1)

1-Eicosenoyl-2-pentadecanoyl-sn-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

PC(12:0/20:1(11Z))

1-dodecanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

PC(13:0/19:1(9Z))

1-tridecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

PC(15:0/17:1(9Z))

1-pentadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

PC(15:1(9Z)/17:0)

1-(9Z-pentadecenoyl)-2-heptadecanoyl-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

PC(17:0/15:1(9Z))

1-heptadecanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

PC(17:1(9Z)/15:0)

1-(9Z-heptadecenoyl)-2-pentadecanoyl-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

PC(19:1(9Z)/13:0)

1-(9Z-nonadecenoyl)-2-tridecanoyl-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

PC(20:1(11Z)/12:0)

1-(11Z-eicosenoyl)-2-dodecanoyl-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

PE(13:0/22:1(11Z))

1-tridecanoyl-2-(11Z-docosenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

PE(14:1(9Z)/21:0)

1-(9Z-tetradecenoyl)-2-heneicosanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

PE(15:1(9Z)/20:0)

1-(9Z-pentadecenoyl)-2-eicosanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

PE(16:0/19:1(9Z))

1-hexadecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

PE(16:1(9Z)/19:0)

1-(9Z-hexadecenoyl)-2-nonadecanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

PE(17:1(9Z)/18:0)

1-(9Z-heptadecenoyl)-2-octadecanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

PE(18:0/17:1(9Z))

1-octadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

PE(18:1(9Z)/17:0)

1-(9Z-octadecenoyl)-2-heptadecanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

PE(19:0/16:1(9Z))

1-nonadecanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

PE(19:1(9Z)/16:0)

1-(9Z-nonadecenoyl)-2-hexadecanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

PE(20:0/15:1(9Z))

1-eicosanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

PE(21:0/14:1(9Z))

1-heneicosanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

PE(22:1(11Z)/13:0)

1-(11Z-docosenoyl)-2-tridecanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

PE(17:0/18:1(9Z))

1-heptadecanoyl-2-(9Z-octadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

PS(12:0/20:2(11Z,14Z))

1-dodecanoyl-2-(11Z,14Z-eicosadienoyl)-glycero-3-phosphoserine

C38H70NO10P (731.473709)


   

PS(14:1(9Z)/18:1(9Z))

1-(9Z-tetradecenoyl)-2-(9Z-octadecenoyl)-glycero-3-phosphoserine

C38H70NO10P (731.473709)


   

PS(15:0/17:2(9Z,12Z))

1-pentadecanoyl-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphoserine

C38H70NO10P (731.473709)


   

PS(15:1(9Z)/17:1(9Z))

1-(9Z-pentadecenoyl)-2-(9Z-heptadecenoyl)-glycero-3-phosphoserine

C38H70NO10P (731.473709)


   

PS(17:1(9Z)/15:1(9Z))

1-(9Z-heptadecenoyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphoserine

C38H70NO10P (731.473709)


   

PS(17:2(9Z,12Z)/15:0)

1-(9Z,12Z-heptadecadienoyl)-2-pentadecanoyl-glycero-3-phosphoserine

C38H70NO10P (731.473709)


   

PS(18:1(9Z)/14:1(9Z))

1-(9Z-octadecenoyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphoserine

C38H70NO10P (731.473709)


   

PS(18:2(9Z,12Z)/14:0)

1-(9Z,12Z-octadecadienoyl)-2-tetradecanoyl-glycero-3-phosphoserine

C38H70NO10P (731.473709)


   

PS(20:2(11Z,14Z)/12:0)

1-(11Z,14Z-eicosadienoyl)-2-dodecanoyl-glycero-3-phosphoserine

C38H70NO10P (731.473709)


   

PS(14:0/18:2(9Z,12Z))

1-tetradecanoyl-2-(9Z,12Z-octadecadienoyl)-glycero-3-phosphoserine

C38H70NO10P (731.473709)


   

PS(16:1(9Z)/16:1(9Z))

1,2-di-(9Z-hexadecenoyl)-sn-glycero-3-phosphoserine

C38H70NO10P (731.473709)


   

PS(O-16:0/17:2(9Z,12Z))

1-hexadecyl-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphoserine

C39H74NO9P (731.5100924)


   

PS(P-16:0/17:1(9Z))

1-(1Z-hexadecenyl)-2-(9Z-heptadecenoyl)-glycero-3-phosphoserine

C39H74NO9P (731.5100924)


   

PS(P-18:0/15:1(9Z))

1-(1Z-octadecenyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphoserine

C39H74NO9P (731.5100924)


   

Araliacerebroside

N-[(8E)-3,4-dihydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-8-en-2-yl]-2-hydroxyhexadecanamide

C40H77NO10 (731.5547182)


   

PE-NMe 34:1

9-Octadecenoic acid (Z)-, 4-hydroxy-1-[[(1-oxohexadecyl)oxy]methyl]-3,5-dioxa-8-aza-4-phosphanon-1-yl ester, P-oxide, (R)-

C40H78NO8P (731.5464757999999)


   

PE 35:1

1-hexadecanoyl-2-(11R, 12S-methylene-octadecanoyl)-sn-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

PE dO-38:8

1-(6-[3]-ladderane-hexanyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine

C43H74NO6P (731.5253473999999)


   

PS 32:2

1-(9Z,12Z-heptadecadienoyl)-2-pentadecanoyl-glycero-3-phosphoserine

C38H70NO10P (731.473709)


   

PS O-33:2

1-(1Z-octadecenyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphoserine

C39H74NO9P (731.5100924)


   

OHODA-PC

1-(9Z-octadecenoyl)-2-(9-hydroxy-12-oxo-10E-dodecenoyl)-sn-glycero-3-phosphocholine

C38H70NO10P (731.473709)


   

HexCer 34:1;O4

N-(2R-hydroxyhexadecanoyl)-1-beta-glucosyl-4R-hydroxy-8Z-octadecasphingenine

C40H77NO10 (731.5547182)


   

MMAF

2-[[3-Methoxy-3-[1-[3-methoxy-5-methyl-4-[methyl-[3-methyl-2-[[3-methyl-2-(methylamino)butanoyl]amino]butanoyl]amino]heptanoyl]pyrrolidin-2-yl]-2-methylpropanoyl]amino]-3-phenylpropanoic acid

C39H65N5O8 (731.483289)


   

1-tetradecanoyl-2-[(9Z)-octadecenoyl]-sn-glycero-3-phosphocholine

1-tetradecanoyl-2-[(9Z)-octadecenoyl]-sn-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


A phosphatidylcholine 32:1 in which the acyl groups at C-1 and C-2 are tetradecanoyl and (9Z)-octadecenoyl respectively.

   

1-Palmitoyl-2-palmitoleoylphosphatidylcholine

1-Palmitoyl-2-palmitoleoylphosphatidylcholine

C40H78NO8P (731.5464757999999)


   

Phosphatidylethanolamine (1-palmitoyl, 2-lactobacilloyl)

Phosphatidylethanolamine (1-palmitoyl, 2-lactobacilloyl)

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[10-(2-hexylcyclopropyl)decanoyloxy]propyl] hexadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[10-(2-hexylcyclopropyl)decanoyloxy]propyl] hexadecanoate

C40H78NO8P (731.5464757999999)


   
   

PE(16:0/18:1(12Z)-O(9S,10R))

PE(16:0/18:1(12Z)-O(9S,10R))

C39H74NO9P (731.5100924)


   

PE(18:1(12Z)-O(9S,10R)/16:0)

PE(18:1(12Z)-O(9S,10R)/16:0)

C39H74NO9P (731.5100924)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropyl] hexadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropyl] hexadecanoate

C39H74NO9P (731.5100924)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropan-2-yl] hexadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropan-2-yl] hexadecanoate

C39H74NO9P (731.5100924)


   

2-[[(2S,3R,4E,8Z)-2-[[(Z,9S,10S)-9,10-dihydroxyoctadec-12-enoyl]amino]-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S,3R,4E,8Z)-2-[[(Z,9S,10S)-9,10-dihydroxyoctadec-12-enoyl]amino]-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C39H76N2O8P+ (731.5339006)


   

[(3S)-3-[[(2S)-2-[[(2R,4R)-2,4-dimethyloctanoyl]-methylamino]-4-methylpentanoyl]amino]-4-[methyl-[(2S)-3-methyl-1-[(2S)-2-[(2S)-2-methyl-5-oxo-2H-pyrrole-1-carbonyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]amino]-4-oxobutan-2-yl] acetate

[(3S)-3-[[(2S)-2-[[(2R,4R)-2,4-dimethyloctanoyl]-methylamino]-4-methylpentanoyl]amino]-4-[methyl-[(2S)-3-methyl-1-[(2S)-2-[(2S)-2-methyl-5-oxo-2H-pyrrole-1-carbonyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]amino]-4-oxobutan-2-yl] acetate

C39H65N5O8 (731.483289)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (Z)-octadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (Z)-octadec-9-enoate

C40H78NO8P (731.5464757999999)


   
   
   
   

HexCer 13:0;2O/24:6

HexCer 13:0;2O/24:6

C43H73NO8 (731.5335898)


   

HexCer 17:2;2O/20:4

HexCer 17:2;2O/20:4

C43H73NO8 (731.5335898)


   

HexCer 21:2;2O/16:4

HexCer 21:2;2O/16:4

C43H73NO8 (731.5335898)


   

HexCer 13:1;2O/24:5

HexCer 13:1;2O/24:5

C43H73NO8 (731.5335898)


   

HexCer 15:3;2O/22:3

HexCer 15:3;2O/22:3

C43H73NO8 (731.5335898)


   

HexCer 19:1;2O/18:5

HexCer 19:1;2O/18:5

C43H73NO8 (731.5335898)


   

HexCer 17:3;2O/20:3

HexCer 17:3;2O/20:3

C43H73NO8 (731.5335898)


   

HexCer 13:2;2O/24:4

HexCer 13:2;2O/24:4

C43H73NO8 (731.5335898)


   

HexCer 21:3;2O/16:3

HexCer 21:3;2O/16:3

C43H73NO8 (731.5335898)


   

HexCer 15:1;2O/22:5

HexCer 15:1;2O/22:5

C43H73NO8 (731.5335898)


   

HexCer 17:1;2O/20:5

HexCer 17:1;2O/20:5

C43H73NO8 (731.5335898)


   

HexCer 19:2;2O/18:4

HexCer 19:2;2O/18:4

C43H73NO8 (731.5335898)


   

HexCer 11:1;2O/26:5

HexCer 11:1;2O/26:5

C43H73NO8 (731.5335898)


   

HexCer 15:0;2O/22:6

HexCer 15:0;2O/22:6

C43H73NO8 (731.5335898)


   

HexCer 19:3;2O/18:3

HexCer 19:3;2O/18:3

C43H73NO8 (731.5335898)


   

HexCer 15:2;2O/22:4

HexCer 15:2;2O/22:4

C43H73NO8 (731.5335898)


   

HexCer 11:0;2O/26:6

HexCer 11:0;2O/26:6

C43H73NO8 (731.5335898)


   
   
   
   
   
   
   

[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H70NO7P (731.4889639999999)


   

2-[3-nonanoyloxy-2-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[3-nonanoyloxy-2-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C43H73NO8 (731.5335898)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

2-[3-[(Z)-heptadec-9-enoyl]oxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[3-[(Z)-heptadec-9-enoyl]oxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C43H73NO8 (731.5335898)


   

2-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C43H73NO8 (731.5335898)


   

2-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C43H73NO8 (731.5335898)


   

2-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-tridecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-tridecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C43H73NO8 (731.5335898)


   

2-[2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxy-3-pentadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxy-3-pentadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C43H73NO8 (731.5335898)


   

2-[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C43H73NO8 (731.5335898)


   

2-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-undecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-undecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C43H73NO8 (731.5335898)


   

HexCer 8:0;3O/26:1;(2OH)

HexCer 8:0;3O/26:1;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 9:0;3O/25:1;(2OH)

HexCer 9:0;3O/25:1;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 13:1;3O/21:0;(2OH)

HexCer 13:1;3O/21:0;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 13:0;3O/21:1;(2OH)

HexCer 13:0;3O/21:1;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 12:0;3O/22:1;(2OH)

HexCer 12:0;3O/22:1;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 12:1;3O/22:0;(2OH)

HexCer 12:1;3O/22:0;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 11:0;3O/23:1;(2OH)

HexCer 11:0;3O/23:1;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 10:0;3O/24:1;(2OH)

HexCer 10:0;3O/24:1;(2OH)

C40H77NO10 (731.5547182)


   

(4E,8E,12E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]icosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]icosa-4,8,12-triene-1-sulfonic acid

C44H77NO5S (731.5522152)


   

(E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]hexacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]hexacos-4-ene-1-sulfonic acid

C44H77NO5S (731.5522152)


   

(4E,8E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]icosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]icosa-4,8-diene-1-sulfonic acid

C44H77NO5S (731.5522152)


   

(E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxydocos-4-ene-1-sulfonic acid

(E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxydocos-4-ene-1-sulfonic acid

C44H77NO5S (731.5522152)


   

(4E,8E,12E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxyoctadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxyoctadeca-4,8,12-triene-1-sulfonic acid

C44H77NO5S (731.5522152)


   

(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]hexacosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]hexacosa-4,8,12-triene-1-sulfonic acid

C44H77NO5S (731.5522152)


   

(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]hexacosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]hexacosa-4,8-diene-1-sulfonic acid

C44H77NO5S (731.5522152)


   

(E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxyoctadec-4-ene-1-sulfonic acid

(E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxyoctadec-4-ene-1-sulfonic acid

C44H77NO5S (731.5522152)


   

(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]icos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]icos-4-ene-1-sulfonic acid

C44H77NO5S (731.5522152)


   

3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]icosane-1-sulfonic acid

3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]icosane-1-sulfonic acid

C44H77NO5S (731.5522152)


   

(4E,8E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxydocosa-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxydocosa-4,8-diene-1-sulfonic acid

C44H77NO5S (731.5522152)


   

(4E,8E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxyoctadeca-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxyoctadeca-4,8-diene-1-sulfonic acid

C44H77NO5S (731.5522152)


   

2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxydocosane-1-sulfonic acid

2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxydocosane-1-sulfonic acid

C44H77NO5S (731.5522152)


   

(E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]tetracos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]tetracos-4-ene-1-sulfonic acid

C44H77NO5S (731.5522152)


   

(4E,8E,12E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxydocosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxydocosa-4,8,12-triene-1-sulfonic acid

C44H77NO5S (731.5522152)


   

(4E,8E,12E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]tetracosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]tetracosa-4,8,12-triene-1-sulfonic acid

C44H77NO5S (731.5522152)


   

2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxyoctadecane-1-sulfonic acid

2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxyoctadecane-1-sulfonic acid

C44H77NO5S (731.5522152)


   

(4E,8E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]tetracosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]tetracosa-4,8-diene-1-sulfonic acid

C44H77NO5S (731.5522152)


   

2-amino-3-[hydroxy-[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-tetradecanoyloxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-tetradecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[hydroxy-[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-tetradecoxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-tetradecoxypropoxy]phosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[[3-heptadecoxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-heptadecoxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[[3-dodecoxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-dodecoxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[hydroxy-[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-pentadecanoyloxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-pentadecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[[3-[(Z)-heptadec-9-enoxy]-2-[(Z)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-[(Z)-heptadec-9-enoxy]-2-[(Z)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[hydroxy-[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propoxy]phosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-undecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-undecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[hydroxy-[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoxy]propoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoxy]propoxy]phosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[hydroxy-[3-[(Z)-octadec-9-enoxy]-2-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[3-[(Z)-octadec-9-enoxy]-2-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[hydroxy-[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-tridecoxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-tridecoxypropoxy]phosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[[2-dodecanoyloxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-dodecanoyloxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hexadecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hexadecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[hydroxy-[3-[(Z)-nonadec-9-enoxy]-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[3-[(Z)-nonadec-9-enoxy]-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H70NO7P (731.4889639999999)


   

2-amino-3-[hydroxy-[2-[(Z)-octadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoxy]propoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[2-[(Z)-octadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoxy]propoxy]phosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[hydroxy-[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-tridecanoyloxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-tridecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[hydroxy-[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-pentadecoxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-pentadecoxypropoxy]phosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-hexadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-hexadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[hydroxy-[3-[(Z)-icos-11-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[3-[(Z)-icos-11-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[[2-heptadecanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-heptadecanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-amino-3-[[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-hexadecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-hexadecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H74NO9P (731.5100924)


   

2-[4-[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid

2-[4-[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid

C42H69NO7S (731.4794483999999)


   

2-[4-[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid

2-[4-[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid

C43H73NO6S (731.5158317999999)


   

Cer 15:0;2O/16:5;(3OH)(FA 16:5)

Cer 15:0;2O/16:5;(3OH)(FA 16:5)

C47H73NO5 (731.5488447999999)


   
   
   
   

HexCer 22:0;3O/12:1;(2OH)

HexCer 22:0;3O/12:1;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 17:1;3O/17:0;(2OH)

HexCer 17:1;3O/17:0;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 22:1;3O/12:0;(2OH)

HexCer 22:1;3O/12:0;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 19:1;3O/15:0;(2OH)

HexCer 19:1;3O/15:0;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 20:1;3O/14:0;(2OH)

HexCer 20:1;3O/14:0;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 14:1;3O/20:0;(2OH)

HexCer 14:1;3O/20:0;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 15:1;3O/19:0;(2OH)

HexCer 15:1;3O/19:0;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 16:1;3O/18:0;(2OH)

HexCer 16:1;3O/18:0;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 21:0;3O/13:1;(2OH)

HexCer 21:0;3O/13:1;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 14:0;3O/20:1;(2OH)

HexCer 14:0;3O/20:1;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 20:0;3O/14:1;(2OH)

HexCer 20:0;3O/14:1;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 16:0;3O/18:1;(2OH)

HexCer 16:0;3O/18:1;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 19:0;3O/15:1;(2OH)

HexCer 19:0;3O/15:1;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 21:1;3O/13:0;(2OH)

HexCer 21:1;3O/13:0;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 18:0;3O/16:1;(2OH)

HexCer 18:0;3O/16:1;(2OH)

C40H77NO10 (731.5547182)


   

HexCer 15:0;3O/19:1;(2OH)

HexCer 15:0;3O/19:1;(2OH)

C40H77NO10 (731.5547182)


   

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H70NO7P (731.4889639999999)


   

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H70NO7P (731.4889639999999)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] octadecanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] octadecanoate

C40H78NO8P (731.5464757999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (Z)-icos-11-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (Z)-icos-11-enoate

C40H78NO8P (731.5464757999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (Z)-docos-13-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (Z)-docos-13-enoate

C40H78NO8P (731.5464757999999)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] nonadecanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] nonadecanoate

C40H78NO8P (731.5464757999999)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] icosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] icosanoate

C40H78NO8P (731.5464757999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (Z)-nonadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (Z)-nonadec-9-enoate

C40H78NO8P (731.5464757999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (Z)-tetracos-13-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (Z)-tetracos-13-enoate

C40H78NO8P (731.5464757999999)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] henicosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] henicosanoate

C40H78NO8P (731.5464757999999)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] docosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] docosanoate

C40H78NO8P (731.5464757999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (Z)-henicos-11-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (Z)-henicos-11-enoate

C40H78NO8P (731.5464757999999)


   

[2-[(Z)-octadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-octadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[3-dodecanoyloxy-2-[(Z)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-dodecanoyloxy-2-[(Z)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[2-[(Z)-nonadec-9-enoyl]oxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-nonadec-9-enoyl]oxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[3-heptadecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-heptadecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[3-octadecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-octadecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-hexacos-15-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-hexacos-15-enoate

C40H78NO8P (731.5464757999999)


   

[3-nonadecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-nonadecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[2-[(Z)-hexacos-15-enoyl]oxy-3-hexanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-hexacos-15-enoyl]oxy-3-hexanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[3-decanoyloxy-2-[(Z)-docos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-decanoyloxy-2-[(Z)-docos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[3-octanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-octanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[2-[(Z)-heptadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-heptadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[2-[(Z)-henicos-11-enoyl]oxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-henicos-11-enoyl]oxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[(E)-octadec-13-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-octadec-13-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-2-[(E)-octadec-7-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-octadec-7-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-dodecanoyloxy-2-[(E)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-dodecanoyloxy-2-[(E)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] (E)-docos-13-enoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] (E)-docos-13-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-heptadecanoyloxy-2-[(E)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-heptadecanoyloxy-2-[(E)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] octadec-17-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] octadec-17-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] icosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] icosanoate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-heptadec-9-enoyl]oxypropyl] octadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-heptadec-9-enoyl]oxypropyl] octadecanoate

C40H78NO8P (731.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-7-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-7-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (E)-icos-11-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (E)-icos-11-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-octadecanoyloxy-2-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-octadecanoyloxy-2-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[(E)-heptadec-9-enoyl]oxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-heptadec-9-enoyl]oxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-2-[(E)-octadec-6-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-octadec-6-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (E)-docos-13-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (E)-docos-13-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-9-enoyl]oxypropyl] nonadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-9-enoyl]oxypropyl] nonadecanoate

C40H78NO8P (731.5464757999999)


   

[(2R)-2-[(E)-octadec-11-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-octadec-11-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-6-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-6-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-2-heptadecanoyloxy-3-[(E)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-heptadecanoyloxy-3-[(E)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-2-hexadecanoyloxy-3-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-hexadecanoyloxy-3-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2S)-2-dodecanoyloxy-3-[(E)-icos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-2-dodecanoyloxy-3-[(E)-icos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-pentadec-9-enoyl]oxypropyl] icosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-pentadec-9-enoyl]oxypropyl] icosanoate

C40H78NO8P (731.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-11-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-11-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-octadec-17-enoyloxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-octadec-17-enoyloxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (E)-icos-13-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (E)-icos-13-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-11-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-11-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[(E)-octadec-9-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-octadec-9-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-7-enoyl]oxypropyl] nonadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-7-enoyl]oxypropyl] nonadecanoate

C40H78NO8P (731.5464757999999)


   

[(2R)-2-[(E)-octadec-4-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-octadec-4-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-dodecanoyloxy-2-[(E)-icos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-dodecanoyloxy-2-[(E)-icos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-hexadecanoyloxy-2-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-hexadecanoyloxy-2-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-2-octadec-17-enoyloxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-octadec-17-enoyloxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-tetracos-15-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-tetracos-15-enoate

C40H78NO8P (731.5464757999999)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] (E)-icos-11-enoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] (E)-icos-11-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-6-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-6-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] henicosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] henicosanoate

C40H78NO8P (731.5464757999999)


   

[(2R)-2-[(E)-octadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-octadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-9-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-9-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-decanoyloxy-2-[(E)-docos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-decanoyloxy-2-[(E)-docos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-7-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-7-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-4-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-4-enoate

C40H78NO8P (731.5464757999999)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] (E)-icos-13-enoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] (E)-icos-13-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-hexadecanoyloxy-2-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-hexadecanoyloxy-2-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-tetradec-9-enoyl]oxypropyl] henicosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-tetradec-9-enoyl]oxypropyl] henicosanoate

C40H78NO8P (731.5464757999999)


   

[(2R)-2-hexadecanoyloxy-3-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-hexadecanoyloxy-3-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-2-[(E)-heptadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-heptadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-7-enoyl]oxypropan-2-yl] nonadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-7-enoyl]oxypropan-2-yl] nonadecanoate

C40H78NO8P (731.5464757999999)


   

[(2R)-2-[(E)-octadec-13-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-octadec-13-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-9-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-9-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[(E)-octadec-6-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-octadec-6-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-2-octadecanoyloxy-3-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-octadecanoyloxy-3-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-13-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-13-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-13-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-13-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-4-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-4-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] octadec-17-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] octadec-17-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-heptadec-9-enoyl]oxypropan-2-yl] octadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-heptadec-9-enoyl]oxypropan-2-yl] octadecanoate

C40H78NO8P (731.5464757999999)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] (E)-tetracos-15-enoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] (E)-tetracos-15-enoate

C40H78NO8P (731.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-9-enoyl]oxypropan-2-yl] nonadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-9-enoyl]oxypropan-2-yl] nonadecanoate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[(E)-octadec-7-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-octadec-7-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2S)-2-dodecanoyloxy-3-[(E)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-2-dodecanoyloxy-3-[(E)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[(E)-octadec-4-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-octadec-4-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2S)-2-decanoyloxy-3-[(E)-docos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-2-decanoyloxy-3-[(E)-docos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

[(2R)-3-[(E)-octadec-11-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-octadec-11-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)


   

2-[[(E)-2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]amino]-3-hydroxyundec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]amino]-3-hydroxyundec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H72N2O6P+ (731.5127722)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]heptadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]heptadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C42H72N2O6P+ (731.5127722)


   

2-[[(4E,8E,12E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxypentadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxypentadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H72N2O6P+ (731.5127722)


   

2-[[(4E,8E)-2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxypentadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxypentadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H72N2O6P+ (731.5127722)


   

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]trideca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]trideca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C42H72N2O6P+ (731.5127722)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoyl]amino]non-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoyl]amino]non-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C42H72N2O6P+ (731.5127722)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]nonadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]nonadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C42H72N2O6P+ (731.5127722)


   

1-Oleoyl-2-myristoyl-sn-glycero-3-phosphocholine

1-Oleoyl-2-myristoyl-sn-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

1-Palmitoyl-2-palmitoleoyl-sn-glycero-3-phosphocholine

1-Palmitoyl-2-palmitoleoyl-sn-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


A phosphatidylcholine 32:1 in which the acyl groups at C-1 and C-2 are hexadecanoyl and (9Z)-hexadec-9-enoyl respectively.

   

1-Palmitoleoyl-2-palmitoyl-sn-glycero-3-phosphocholine

1-Palmitoleoyl-2-palmitoyl-sn-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


A phosphatidylcholine 16:0_16:1 in which the acyl groups specified at positions 1 and 2 are palmitoleoyl and palmitoyl respectively.

   

1-(9Z-tetradecenoyl)-2-octadecanoyl-glycero-3-phosphocholine

1-(9Z-tetradecenoyl)-2-octadecanoyl-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   
   
   

1-tetradecanoyl-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

1-tetradecanoyl-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


A phosphatidylcholine 32:1 in which the acyl groups at C-1 and C-2 are tetradecanoyl and (11Z)-octadec-11-enoyl respectively.

   
   

1-pentadecanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphoethanolamine

1-pentadecanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

1-(11Z-eicosenoyl)-2-pentadecanoyl-glycero-3-phosphoethanolamine

1-(11Z-eicosenoyl)-2-pentadecanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   
   
   
   
   
   
   
   
   
   
   
   

1-(9Z-heptadecenoyl)-2-octadecanoyl-glycero-3-phosphoethanolamine

1-(9Z-heptadecenoyl)-2-octadecanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

1-octadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphoethanolamine

1-octadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

1-dodecanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphocholine

1-dodecanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

1-(9Z-tetradecenoyl)-2-heneicosanoyl-glycero-3-phosphoethanolamine

1-(9Z-tetradecenoyl)-2-heneicosanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

1-tridecanoyl-2-(11Z-docosenoyl)-glycero-3-phosphoethanolamine

1-tridecanoyl-2-(11Z-docosenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

1-tridecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphocholine

1-tridecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

1-(9Z-pentadecenoyl)-2-heptadecanoyl-glycero-3-phosphocholine

1-(9Z-pentadecenoyl)-2-heptadecanoyl-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

1-heptadecanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphocholine

1-heptadecanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

1-(9Z-heptadecenoyl)-2-pentadecanoyl-glycero-3-phosphocholine

1-(9Z-heptadecenoyl)-2-pentadecanoyl-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

1-(9Z-nonadecenoyl)-2-tridecanoyl-glycero-3-phosphocholine

1-(9Z-nonadecenoyl)-2-tridecanoyl-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

1-pentadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphocholine

1-pentadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

1-(11Z-eicosenoyl)-2-dodecanoyl-glycero-3-phosphocholine

1-(11Z-eicosenoyl)-2-dodecanoyl-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


   

1-(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-N-methylethanolamine

1-(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-N-methylethanolamine

C40H78NO8P (731.5464757999999)


   

1-(9Z-octadecenoyl)-2-heptadecanoyl-glycero-3-phosphoethanolamine

1-(9Z-octadecenoyl)-2-heptadecanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

1-nonadecanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphoethanolamine

1-nonadecanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

1-eicosanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphoethanolamine

1-eicosanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

1-(9Z-pentadecenoyl)-2-eicosanoyl-glycero-3-phosphoethanolamine

1-(9Z-pentadecenoyl)-2-eicosanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

1-hexadecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphoethanolamine

1-hexadecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

1-(9Z-hexadecenoyl)-2-nonadecanoyl-glycero-3-phosphoethanolamine

1-(9Z-hexadecenoyl)-2-nonadecanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

1-(9Z-nonadecenoyl)-2-hexadecanoyl-glycero-3-phosphoethanolamine

1-(9Z-nonadecenoyl)-2-hexadecanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

1-heneicosanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphoethanolamine

1-heneicosanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

1-heptadecanoyl-2-(9Z-octadecenoyl)-glycero-3-phosphoethanolamine

1-heptadecanoyl-2-(9Z-octadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

1-(11Z-docosenoyl)-2-tridecanoyl-glycero-3-phosphoethanolamine

1-(11Z-docosenoyl)-2-tridecanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)


   

phosphatidylethanolamine 35:1

phosphatidylethanolamine 35:1

C40H78NO8P (731.5464757999999)


A phosphatidylethanolamine in which the two acyl groups contain a total of 35 carbons and 1 double bond.

   

phosphatidylcholine 32:1

phosphatidylcholine 32:1

C40H78NO8P (731.5464757999999)


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 32 carbons in total with 1 double bond.

   

phosphatidylethanolamine (15:0/20:1)

phosphatidylethanolamine (15:0/20:1)

C40H78NO8P (731.5464757999999)


A phosphatidylethanolamine 35:1 in which the acyl group at C-1 contains 15 carbons and no double bonds while that at C-2 contains 20 carbons and 1 double bond.

   

phosphatidylethanolamine (16:0/19:1)

phosphatidylethanolamine (16:0/19:1)

C40H78NO8P (731.5464757999999)


A phosphatidylethanolamine 35:1 in which the acyl group at C-1 contains 16 carbons and no double bonds while that at C-2 contains 19 carbons and 1 double bond.

   

phosphatidylethanolamine (17:0/18:1)

phosphatidylethanolamine (17:0/18:1)

C40H78NO8P (731.5464757999999)


A phosphatidylethanolamine 35:1 in which the acyl group at C-1 contains 17 carbons and no double bonds while that at C-2 contains 18 carbons and 1 double bond.

   

phosphatidylethanolamine (17:1/18:0)

phosphatidylethanolamine (17:1/18:0)

C40H78NO8P (731.5464757999999)


A phosphatidylethanolamine 35:1 in which the acyl group at C-1 contains 17 carbons and 1 double bond while that at C-2 contains 18 carbons and no double bonds.

   

phosphatidylcholine (16:0/16:1)

phosphatidylcholine (16:0/16:1)

C40H78NO8P (731.5464757999999)


A phosphatidylcholine 32:1 in which the fatty acyl groups at positions 1 and 2 are specified as C16:0 and C16:1 respectively.

   

1-[(9Z)-octadecenoyl]-2-tetradecanoyl-sn-glycero-3-phosphocholine

1-[(9Z)-octadecenoyl]-2-tetradecanoyl-sn-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


A phosphatidylcholine 32:1 in which the acyl groups specified at positions 1 and 2 are oleoyl and myristoyl respectively.

   
   

MePC(31:1)

MePC(15:0_16:1)

C40H78NO8P (731.5464757999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

PC(34:8)

PC(20:4(1)_14:4)

C42H70NO7P (731.4889639999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

CerP(40:2)

CerP(t20:1_20:1(1+O))

C40H78NO8P (731.5464757999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

CerP(43:7)

CerP(d18:2_25:5)

C43H74NO6P (731.5253473999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hex1Cer(37:6)

Hex1Cer(d15:0_22:6)

C43H73NO8 (731.5335898)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

dMePE(33:1)

dMePE(17:1_16:0)

C40H78NO8P (731.5464757999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hex1Cer(34:1)

Hex1Cer(d18:1_16:0(2+O))

C40H77NO10 (731.5547182)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

PS P-16:0/17:1 or PS O-16:1/17:1

PS P-16:0/17:1 or PS O-16:1/17:1

C39H74NO9P (731.5100924)


   
   

PS P-16:1/17:0 or PS O-16:2/17:0

PS P-16:1/17:0 or PS O-16:2/17:0

C39H74NO9P (731.5100924)


   
   

PS P-18:0/15:1 or PS O-18:1/15:1

PS P-18:0/15:1 or PS O-18:1/15:1

C39H74NO9P (731.5100924)


   
   

PS P-18:1/15:0 or PS O-18:2/15:0

PS P-18:1/15:0 or PS O-18:2/15:0

C39H74NO9P (731.5100924)


   
   

PS P-20:1/13:0 or PS O-20:2/13:0

PS P-20:1/13:0 or PS O-20:2/13:0

C39H74NO9P (731.5100924)


   
   

PS P-22:1/11:0 or PS O-22:2/11:0

PS P-22:1/11:0 or PS O-22:2/11:0

C39H74NO9P (731.5100924)


   
   

PS P-33:1 or PS O-33:2

PS P-33:1 or PS O-33:2

C39H74NO9P (731.5100924)


   
   
   
   

GalCer 15:0;O2/22:6

GalCer 15:0;O2/22:6

C43H73NO8 (731.5335898)


   

GalCer 15:1;O2/22:5

GalCer 15:1;O2/22:5

C43H73NO8 (731.5335898)


   

GalCer 15:2;O2/22:4

GalCer 15:2;O2/22:4

C43H73NO8 (731.5335898)


   

GalCer 17:1;O2/20:5

GalCer 17:1;O2/20:5

C43H73NO8 (731.5335898)


   

GalCer 17:2;O2/20:4

GalCer 17:2;O2/20:4

C43H73NO8 (731.5335898)


   

GalCer 19:2;O2/18:4

GalCer 19:2;O2/18:4

C43H73NO8 (731.5335898)


   
   

GlcCer 15:0;O2/22:6

GlcCer 15:0;O2/22:6

C43H73NO8 (731.5335898)


   

GlcCer 15:1;O2/22:5

GlcCer 15:1;O2/22:5

C43H73NO8 (731.5335898)


   

GlcCer 15:2;O2/22:4

GlcCer 15:2;O2/22:4

C43H73NO8 (731.5335898)


   

GlcCer 17:1;O2/20:5

GlcCer 17:1;O2/20:5

C43H73NO8 (731.5335898)


   

GlcCer 17:2;O2/20:4

GlcCer 17:2;O2/20:4

C43H73NO8 (731.5335898)


   

GlcCer 19:2;O2/18:4

GlcCer 19:2;O2/18:4

C43H73NO8 (731.5335898)


   
   

HexCer 15:0;O2/22:6

HexCer 15:0;O2/22:6

C43H73NO8 (731.5335898)


   

HexCer 15:1;O2/22:5

HexCer 15:1;O2/22:5

C43H73NO8 (731.5335898)


   

HexCer 15:2;O2/22:4

HexCer 15:2;O2/22:4

C43H73NO8 (731.5335898)


   

HexCer 17:1;O2/20:5

HexCer 17:1;O2/20:5

C43H73NO8 (731.5335898)


   

HexCer 17:2;O2/20:4

HexCer 17:2;O2/20:4

C43H73NO8 (731.5335898)


   

HexCer 19:2;O2/18:4

HexCer 19:2;O2/18:4

C43H73NO8 (731.5335898)


   
   
   

(2s)-n-[(1s,2r)-2-(acetyloxy)-1-{methyl[(2s)-3-methyl-1-[(2s)-2-(2-methyl-5-oxo-2h-pyrrole-1-carbonyl)pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamoyl}propyl]-4-methyl-2-[(2r,4r)-n,2,4-trimethyloctanamido]pentanimidic acid

(2s)-n-[(1s,2r)-2-(acetyloxy)-1-{methyl[(2s)-3-methyl-1-[(2s)-2-(2-methyl-5-oxo-2h-pyrrole-1-carbonyl)pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamoyl}propyl]-4-methyl-2-[(2r,4r)-n,2,4-trimethyloctanamido]pentanimidic acid

C39H65N5O8 (731.483289)


   

(9e)-n-(3,4,12-trihydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadecan-2-yl)hexadec-9-enimidic acid

(9e)-n-(3,4,12-trihydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadecan-2-yl)hexadec-9-enimidic acid

C40H77NO10 (731.5547182)